Skip to Content
MilliporeSigma
All Photos(1)

Documents

D152609

Sigma-Aldrich

2,2-Dimethylbutyric acid

96%

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
C2H5C(CH3)2CO2H
CAS Number:
595-37-9
Molecular Weight:
116.16
EC Number:
209-865-0
MDL number:
MFCD00004200
UNSPSC Code:
12352100
PubChem Substance ID:
24893468
NACRES:
NA.22

Quality Level

100

assay

96%

form

liquid

refractive index

n20/D 1.4154 (lit.)

bp

94-96 °C/5 mmHg (lit.)

density

0.928 g/mL at 25 °C (lit.)

SMILES string

CCC(C)(C)C(O)=O

InChI

1S/C6H12O2/c1-4-6(2,3)5(7)8/h4H2,1-3H3,(H,7,8)

InChI key

VUAXHMVRKOTJKP-UHFFFAOYSA-N

Related Categories

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Storage Class

10 - Combustible liquids

wgk_germany

WGK 3

flash_point_f

174.2 °F - closed cup

flash_point_c

79 °C - closed cup

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 6

1 of 6

Diisobutylamine 99%

Sigma-Aldrich

135186

Diisobutylamine

4-(Dimethylamino)butyric acid hydrochloride 98%

Sigma-Aldrich

263737

4-(Dimethylamino)butyric acid hydrochloride

2-Methylvaleric acid 98%

Sigma-Aldrich

109878

2-Methylvaleric acid

4-Methylvaleric acid 99%

Sigma-Aldrich

277827

4-Methylvaleric acid

Phenoxyacetic acid 98%

Sigma-Aldrich

158518

Phenoxyacetic acid

3,3-Dimethylacrylic acid 97%

Sigma-Aldrich

D138606

3,3-Dimethylacrylic acid

Susan P Perrine et al.
Journal of clinical pharmacology, 51(8), 1186-1194 (2011-03-23)
Pharmacologic induction of fetal globin synthesis is an accepted therapeutic strategy for treatment of the beta hemoglobinopathies and thalassemias, as even small increases in hemoglobin F (HbF) levels reduce clinical severity in sickle cell disease (SCD) and reduce anemia in
Yan-li Tang et al.
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 28(7), 627-629 (2004-05-14)
To provide the foundation for reasonable utilization by analyzing the essential oils of Ligularia virgaurea. The essential oils were extracted by using steam distillation and separated with GC capillary columns. The components were quantitatively determined with normalization method, and were
Pramod S Terse et al.
Toxicologic pathology, 39(4), 614-622 (2011-05-12)
ST-20 (sodium 2,2-dimethylbutyrate) is a potential therapeutic agent for treatment of β-thalassemia and sickle cell disease. A subchronic oral toxicity study was conducted in Sprague-Dawley rats (10/sex/dose) at gavage dosages of 0 (vehicle control), 200, 600, or 1,000 mg/kg, once
Elise Wouters et al.
Drug testing and analysis, 11(8), 1183-1191 (2019-04-26)
Indole- and indazole-based synthetic cannabinoid receptor agonists (SCRAs), featuring valine or tert-leucine substituents, are commonly abused new psychoactive substances (NPS). A major metabolic pathway for these SCRAs is hydrolysis of the terminal amide or methylester functionalities. Although these hydrolysis products
Abdullah Kutlar et al.
American journal of hematology, 87(11), 1017-1021 (2012-08-14)
Therapeutics which reduce the pathology in sickle cell syndromes are needed, particularly noncytotoxic therapeutics. Fetal hemoglobin (HbF, α(2) γ(2) ) is established as a major regulator of disease severity; increased HbF levels correlate with milder clinical courses and improved survival.
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service